Stereotaxis (STXS) Other Non Operating Income (2010 - 2026)

Stereotaxis (STXS) reported Other Non Operating Income of -$5000.0 for Q1 2026, down 266.67% quarter-over-quarter from $3000.0 in Q3 2025.

Stereotaxis (STXS) Other Non Operating Income (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has 14 years of Other Non Operating Income data on file, last reported at -$5000.0 in Q1 2026.

  • Other Non Operating Income for Q1 2026 came in at -$5000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$3000.0 (changed N/A YoY), and the FY2025 annual result was $2000.0, changed N/A from the prior year.
  • Other Non Operating Income declined to -$5000.0 in Q1 2026 per STXS's latest filing, from $3000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $27000.0 in Q2 2023 and troughed at -$5000.0 in Q1 2026.
  • A 4-year average of $4142.9 and a median of $3000.0 in 2023 frame the typical range for Other Non Operating Income.
  • The sharpest annual moves came in 2024 and 2025: Other Non Operating Income tumbled 111.11% in 2024, then jumped 66.67% in 2025.
  • A 4-year view of Other Non Operating Income shows it stood at $3000.0 in 2023, then surged by 66.67% to $5000.0 in 2024, then plunged by 40.0% to $3000.0 in 2025, then tumbled by 266.67% to -$5000.0 in 2026.
  • Business Quant data shows STXS's Other Non Operating Income at -$5000.0 in Q1 2026, $3000.0 in Q3 2025, and -$1000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn
10 Stereotaxis 180.48 Mn 165.86 Mn 3.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5,000.00
Sep 30, 2025 3,000.00
Jun 30, 2025 -1,000.00
Sep 30, 2024 5,000.00
Jun 30, 2024 -3,000.00
Dec 31, 2023 3,000.00
Jun 30, 2023 27,000.00
Sep 30, 2021 -17,000.00
Mar 31, 2018 2.59 Mn
Dec 31, 2017 1.24 Mn
Sep 30, 2017 -4.46 Mn
Jun 30, 2017 300,255.00
Mar 31, 2017 3.13 Mn
Dec 31, 2016 7.68 Mn
Sep 30, 2016 -9.85 Mn
Jun 30, 2016 135,370.00
Mar 31, 2016 31,294.00
Dec 31, 2015 507,909.00
Sep 30, 2015 725,356.00
Jun 30, 2015 999,169.00